Page last updated: 2024-10-26

3,3'-diindolylmethane and Capillary Leak Syndrome

3,3'-diindolylmethane has been researched along with Capillary Leak Syndrome in 1 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Capillary Leak Syndrome: A condition characterized by recurring episodes of fluid leaking from capillaries into extra-vascular compartments causing hematocrit to rise precipitously. If not treated, generalized vascular leak can lead to generalized EDEMA; SHOCK; cardiovascular collapse; and MULTIPLE ORGAN FAILURE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elliott, DM1
Nagarkatti, M1
Nagarkatti, PS1

Other Studies

1 other study available for 3,3'-diindolylmethane and Capillary Leak Syndrome

ArticleYear
3,39-Diindolylmethane Ameliorates Staphylococcal Enterotoxin B–Induced Acute Lung Injury through Alterations in the Expression of MicroRNA that Target Apoptosis and Cell-Cycle Arrest in Activated T Cells.
    The Journal of pharmacology and experimental therapeutics, 2016, Volume: 357, Issue:1

    Topics: Acute Lung Injury; Animals; Apoptosis; Apoptosis Regulatory Proteins; Capillary Leak Syndrome; Cell

2016